Bioenterprises Pty Limited

The Australian National University

Biotechnology Australia Pty, Ltd

Thomas Michael Barnes

Philip Ralph Lehrbach

Gregory John Russell-Jones

Toni Marie Antalis

Neil H Goss

Peter L Devine

Michelle A Clark

A class of carrier molecules which when covalently linked to an immunogen enhances the host's immune response to that immunogen, regardless of whether the complex of carrier and immunogen is administered parenterally, enterally, or orally to the host. Also provided are processes for production of the complexes, as well as hybrid DNA sequences encoding the complexes, recombinant DNA molecules bearing the hybrid DNA sequences, transformed hosts and vaccines comprising the complexes, and methods for production of the vaccine.

Immunopotentiation through covalent linkage between immunogen and

Class of carrier molecules which when covalently linked to an immunogen enhances the host's immune response to that immunogen regardless of whether the complex of carrier and immunogen is administered parenterally, enterally, or orally to the host. In addition, processes are provided for production of the complexes, as well as hybrid DNA sequences encoding complexes, recombinant DNA molecules bearing the hybrid DNA sequences, transformant hosts and vaccines comprising the complexes as well as methods for production of the vaccine.

Immunopotentiating complexes comprising TraT proteins

A novel human protein, minactivin, can be produced by recombinant DNA technology, Biologically active native minactivin, peptides derived from minactivin, and their amino acid sequences can also be purified.

Minactivin compositions and antibodies to minactivin

Growing community of inventors

Lane Cove, Australia

Thomas Michael Barnes